SC13

Overview

SC13 is an orally active, selective Flap structure-specific endonuclease 1 ( FEN1 ) inhibitor and mu opioid receptor ( MOR ) activator. SC13 impairs DNA damage repair and induces apoptosis in cancer cells. SC13 activates cGAS-STING signaling, increases chemokine secretion, and promotes CAR-T cell infiltration at solid tumour sites. SC13 can be used for the research of solid tumours and pain.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Pain | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > FLAP | Products > Signaling Pathways > Opioid Receptor | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > STING

Product Information

• Catalog No.: HY-139678
• CAS No.: 2839142-69-5
• Molecular Formula: C26H30N2O5
• Molecular Weight: 450.53
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source